drugset / Trial / NCT07285863

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

NCT07285863

Phase 4 Recruiting 24 enrolled Mayo Clinic ChiRhoClin, Inc. · collab
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.

Timeline

Start
2026-03-11
Primary completion
2027-03
Completion
2028-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Secretin Other / unclassified 0.2 ug/kg Intravenous